(MENAFN- GlobeNewsWire - Nasdaq) Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing LOUISVILLE, Colo., ...
LOUISVILLE, Colo., April 06, 2026 (GLOBE NEWSWIRE)-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including ...
On March 30, 2026, SeaStar Medical Holding Corp. (NASDAQ: ICU) announced two poster presentations at the 31 st International Conference on Advances in Critical Care Nephrology (AKI & CRRT) 2026. The ...
KING OF PRUSSIA, Pa., March 30, 2026 (GLOBE NEWSWIRE) -- SEED Therapeutics, Inc. (“SEED”) , a clinical-stage biotechnology company specializing in molecular glue degraders, today announced that it ...
The Capstone Poster Presentation highlights how final-year engineering students apply their knowledge to real-world challenges. Faculty, industry professionals and the Concordia community are invited ...
Is there a “Super Smash Bros.” movie on the horizon? It sure seems like that’s what “The Super Mario Galaxy Movie” is building up to, with the surprise announcement Thursday that Fox McCloud, of the ...
Daredevil: Born Again Season 2 premieres on Disney+ tonight, and Jon Bernthal has just taken to Instagram to say, "WELCOME. BACK. FRANK." While the vigilante won't be teaming up with the Man Without ...
Student abstract submissions were accepted February 2 - March 23, 2026. Registration to attend will be open throughout the symposium. The Zoom link will be emailed April 1, 2026 or after you register, ...
WALTHAM, Mass., March 20, 2026 (GLOBE NEWSWIRE)-- Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunological, ...
PHILADELPHIA, March 19, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) ...
WESTLAKE VILLAGE, Calif., and DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results